The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.50
Bid: 372.50
Ask: 374.00
Change: 8.50 (2.33%)
Spread: 1.50 (0.403%)
Open: 368.50
High: 374.50
Low: 365.00
Prev. Close: 365.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NGCD NOTIFICATION

5 Sep 2018 07:00

RNS Number : 7740Z
Chemring Group PLC
05 September 2018
 

FOR IMMEDIATE RELEASE 5 SEPTEMBER 2018

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

NGCD NOTIFICATION

 

Chemring is pleased to announce that its US based subsidiary, Chemring Sensors and Electronic Systems (CSES), has been notified that it has been down selected as one of the suppliers on the first stream of the Next Generation Chemical Detector (NGCD1). NGCD1, now known as the Aerosol & Vapour Chemical Agent Detector (AVCAD), is the long-term Program of Record for the US Department of Defense to detect traditional and advanced threat vapours, and liquid and solid aerosols.

 

The resultant contract award, which is expected to be received in the coming months, is expected to take the form of an indefinite delivery, indefinite quantity (IDIQ) contract and will be for the Engineering and Manufacturing Development of the program, together with options for varying quantities of hardware under Low Rate Initial Production and Full Rate Production phases of the program.

 

Michael Ord, Group Chief Executive of Chemring, commented:

 

"As the largest stream under the NGCD Program of Record, the AVCAD award decision is a significant development for Chemring and is the culmination of a number of years of research and development activity. We are delighted to have been chosen on this long-term program."

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY18 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTFZLLBVKFZBBZ
Date   Source Headline
19th Jan 20213:52 pmRNSDirector/PDMR Shareholding
19th Jan 20213:47 pmRNSDirector/PDMR Shareholding
19th Jan 20213:43 pmRNSDirector/PDMR Shareholding
19th Jan 20213:42 pmRNSDirector/PDMR Shareholding
4th Jan 202111:01 amRNSTotal Voting Rights
23rd Dec 202010:07 amRNSHolding(s) in Company
22nd Dec 20201:46 pmRNSCorrection re. Additional Listing
22nd Dec 20201:08 pmRNSAdditional Listing
22nd Dec 20209:39 amRNSHolding(s) in Company
18th Dec 202010:25 amRNSBlock listing Interim Review
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20201:17 pmRNSDirector/PDMR Shareholding
16th Dec 20201:15 pmRNSDirector/PDMR Shareholding
16th Dec 20201:13 pmRNSDirector/PDMR Shareholding
15th Dec 20207:00 amRNSFinal Results
1st Dec 202011:17 amRNSTotal Voting Rights
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Nov 20205:04 pmRNSHolding(s) in Company
4th Nov 20202:53 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Update
2nd Nov 20205:13 pmRNSHolding(s) in Company
2nd Nov 20201:25 pmRNSTotal Voting Rights
23rd Oct 202010:53 amRNSHolding(s) in Company
15th Oct 20204:14 pmRNSHolding(s) in Company
2nd Oct 202012:31 pmRNSHolding(s) in Company
2nd Oct 202010:36 amRNSDirector/PDMR Shareholding
1st Oct 20205:48 pmRNSTotal Voting Rights
30th Sep 20207:00 amRNSContract Awards
24th Sep 20204:08 pmRNSHolding(s) in Company
16th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202011:03 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSTrading Update
11th Sep 202011:49 amRNSHolding(s) in Company
1st Sep 202011:34 amRNSTotal Voting Rights
27th Aug 202012:08 pmRNSSecond Price Monitoring Extn
27th Aug 202012:02 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
21st Aug 20202:44 pmRNSHolding(s) in Company
17th Aug 202012:02 pmRNSPrice Monitoring Extension
12th Aug 202011:30 amRNSHolding(s) in Company
3rd Aug 20209:54 amRNSTotal Voting Rights
31st Jul 202012:07 pmRNSSecond Price Monitoring Extn
31st Jul 202012:02 pmRNSPrice Monitoring Extension
30th Jul 202011:22 amRNSDirector/PDMR Shareholding
30th Jul 202011:18 amRNSDirector/PDMR Shareholding
14th Jul 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.